Telmisartan Patent Expiration
Telmisartan is Used for the treatment of cardiovascular conditions such as myocardial infarction, hypertension, and stroke. It was first introduced by Boehringer Ingelheim
Telmisartan Patents
Given below is the list of patents protecting Telmisartan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Micardis | US8003679 | Use of inhibitors of the renin-angiotensin system |
Oct 06, 2022
(Expired) | Boehringer Ingelheim |
| Micardis | US7998953 | Use of inhibitors of the renin-angiotensin system |
Jun 06, 2020
(Expired) | Boehringer Ingelheim |
| Micardis | US6358986 | Polymorphs of telmisartan |
Jan 10, 2020
(Expired) | Boehringer Ingelheim |
| Micardis | US5591762 | Benzimidazoles useful as angiotensin-11 antagonists |
Jan 07, 2014
(Expired) | Boehringer Ingelheim |
Telmisartan's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List